DIN 02163543 — APO-OXYBUTYNIN 5 MG
APO-OXYBUTYNIN is a tablet of Oxybutynin marketed by APOTEX INC. The full Oxybutynin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02163543
- Brand name
- APO-OXYBUTYNIN
- Active ingredient
- Oxybutynin
- Strength
- 5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Anticholinergic / antispasmodic agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Oxybutynin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02231089 | APO-OXYBUTYNIN | 1 MG | SYRUP | APOTEX INC | DORMANT |
| 02240549 | PMS-OXYBUTYNIN | 2.5 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02223376 | PMS-OXYBUTYNIN | 5 MG | SYRUP | PHARMASCIENCE INC | MARKETED |
| 02240550 | PMS-OXYBUTYNIN | 5 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02299364 | RIVA-OXYBUTYNIN | 5 MG | TABLET | LABORATOIRE RIVA INC. | DORMANT |
| 02230394 | TEVA-OXYBUTYNIN | 5 MG | TABLET | TEVA CANADA LIMITED | MARKETED |